Lufthansa Group logistics companies Lufthansa Cargo, Swiss WorldCargo and time:matters have become full members of industry body Pharma.Aero.
The life sciences and MedTech logistics cross-industry collaborative platform says the new members strengthens its position as a global thought leader and content provider.
The partnership with Pharma.Aero will enable Lufthansa Cargo, Swiss WorldCargo, and time:matters to tap into expertise and resources to address key challenges facing the healthcare supply chain.
Trevor Caswell, chairman of Pharma.Aero, said: “We are thrilled to have Lufthansa Cargo, Swiss WorldCargo and time:matters as part of our global community.
“Onboarding such a significant, global industry leader, with a clear and determined focus on the life sciences and MedTech sector, demonstrates once more the importance of our mission and the value our association provides to the industry.
“We are excited to collaborate and leverage our industry knowledge through forward-thinking projects that offer meaningful content to our industry and result in better access to healthcare for people around the world.”
Ashwin Bhat, chief executive of Lufthansa Cargo, said: “We are very pleased to become part of the Pharma.Aero network and to exchange views directly with all players along the supply and transport chain on current issues in the pharmaceutical industry environment.
“In this way, we gain valuable insights into market developments and can jointly identify and evaluate potentials. The exchange of knowledge sharpens understanding – not only for the needs of business partners and customers, but also for the existing and future demand for products.
“We would like to make our contribution here with our know-how from the Lufthansa Group perspective, work closely together and thus actively shape the future of innovative transport solutions in the airfreight segment.”
Lorenzo Stoll, head of cargo at Swiss International Air Lines, added: “In the cold chain logistics, a robust collaboration system between all parties involved is of extreme value.
“By entering the Pharma.Aero network as a member, we aim to drive knowledge sharing and expertise building even further. In view of this collaboration, we look forward to fostering the dialogue between all relevant actors involved and contributing with our know-how to innovation, digitalization, and sustainability in the air cargo industry.”
“The requirements for cell and gene therapies logistics differ significantly from those of traditional pharmaceutical logistics solutions.
“These therapies put the patient at the center, which makes a robust, reliable, resilient and scalable supply chain essential. As a new member of the Pharma.Aero network, we look forward to contributing our long-standing expertise to the development of a global logistics infrastructure to provide patients with better access to advanced therapies and healthcare services”, said Lars Krosch, chief operating officer at time:matters.